Description: The national map below displays those locations that have received shipments of monoclonal antibody therapeutics under the U.S. Food and Drug Administration Emergency Use Authorization (EUA) authority, within the past several weeks. The monoclonal antibodies treatments Bamlanivimab (Eli Lilly), the combo therapy Bamlanivimab/Etesevimab (Eli Lilly), and the therapeutic cocktail Casirivimab/Imdevimab (Regeneron) are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. Monoclonal antibodies treatments are given to help treat patients with COVID-19.

Click here to access the resource: https://protect-public.hhs.gov/pages/therapeutics-distribution